Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development

Alexandre Androuin, Frederik J Verweij, Guillaume van Niel

Research output: Contribution to journalReview articlepeer-review

Abstract

Extracellular Vesicles (EVs) are released during various pathophysiological processes and reflect the state of their cell of origin. Once released, they can propagate through biological fluids, target cells, deliver their content and elicit functional responses. These specific features would allow their harnessing as biomarkers, drug nano-vehicles and therapeutic intrinsic modulators. However, the further development of their potential therapeutic application is hampered by the lack of knowledge about how EVs behave in vivo. Recent advances in the field of imaging EVs in vivo now allow live-tracking of endogenous and exogenous EV in various model organisms at high spatiotemporal resolution to define their distribution, half-life and fate. This review highlights current imaging tools available to image EVs in vivo and how live imaging especially in the zebrafish embryo can bring further insights into the characterization of EVs dynamics, biodistribution and functions to potentiate their development for therapeutic applications.

Original languageEnglish
Article number113815
Pages (from-to)1-11
Number of pages11
JournalAdvanced Drug Delivery Reviews
Volume176
Early online date29 May 2021
DOIs
Publication statusPublished - Sept 2021
Externally publishedYes

Keywords

  • Biomarkers
  • Drug nano-vehicles
  • Extracellular Vesicles
  • In vivo imaging
  • Intrinsic modulators
  • Live imaging
  • Zebrafish embryo

Fingerprint

Dive into the research topics of 'Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development'. Together they form a unique fingerprint.

Cite this